API reference
Brivaracetam
- CAS number
- 357336-20-0
- Molecular formula
- C11H20N2O2
- Molecular weight
- 212.29 g/mol
About this molecule
Brivaracetam is an orally bioavailable levetiracetam derivative, with anticonvulsant activity. Although the exact mechanism through which brivaracetam exerts its effects is not fully known, this agent targets and binds to synaptic vesicle protein 2A (SV2A) in the brain. This prevents synaptic vesicle exocytosis and the synaptic release of certain, as of yet not fully known, excitatory neurotransmitters. This may inhibit impulse conduction across synapses, decrease neuronal (hyper-)excitability, and may modulate epileptogenesis. SV2A, a membrane glycoprotein present in neuronal synaptic vesicles, plays a key role in action potential-induced neurotransmitter release in the brain.
Source: NCI Thesaurus (NCIt), via PubChem.
Identifiers
- IUPAC name
- (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
- InChIKey
- MSYKRHVOOPPJKU-BDAKNGLRSA-N
- SMILES
- CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N
- PubChem CID
- 9837243
Also known as
Brivaracetam · Briviact · brivaracetamum · (2S)-2-((4R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide · N03AX23 · Rikelta · 2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide · (S)-2-((R)-2-Oxo-4-propylpyrrolidin-1-yl)butanamide
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.